Journal club: Lebrikizumab treatment in adults with asthma - a podcast by BMJ Group
from 2013-02-13T16:34:28
::
::
Jennifer Quint (Thorax’s journal club editor) talks to Dr John Matthews (Genentech) about his New England Journal of Medicine published study into whether lebrikizumab, an interleukin-13 monoclonal antibody, can improve asthma control.
Dr Matthews explains the proposed mechanism behind the treatment and how they found it increased FEV1 in adults for whom inhaled glucocorticoids didn’t control their asthma - especially in those with high periostin levels.
Dr Matthews was involved in the Milly trial. This podcast is intended for healthcare professionals only.
See also:
http://www.nejm.org/doi/full/10.1056/NEJMoa1106469
Further episodes of Thorax podcast
Further podcasts by BMJ Group
Website of BMJ Group